ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

ZNTL Zentalis Pharmaceuticals Inc

11,75
-0,79 (-6,30%)
14 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Zentalis Pharmaceuticals Inc ZNTL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,79 -6,30% 11,75 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
12,57 11,55 13,24 11,75 12,54
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.5.202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202413:03EDGAR2Form 8-K - Current report
07.5.202413:00GLOBEZentalis Pharmaceuticals Reports First Quarter 2024..
01.5.202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02.4.202422:05GLOBEZentalis Pharmaceuticals to Highlight Preclinical Data..
01.4.202423:30GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
02.3.202400:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
29.2.202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29.2.202423:14EDGAR2Form S-3ASR - Automatic shelf registration statement of..
28.2.202413:00GLOBEZentalis Pharmaceuticals to Participate in Upcoming Investor..
27.2.202413:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202413:04EDGAR2Form 8-K - Current report
27.2.202413:00GLOBEZentalis Pharmaceuticals Reports Full Year 2023 Financial..
15.2.202422:12EDGAR2Form 8-K - Current report
14.2.202401:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202413:00GLOBEZentalis Pharmaceuticals to Participate in the Oppenheimer..
13.2.202402:25EDGAR2Form 144 - Report of proposed sale of securities
13.2.202402:25EDGAR2Form 144 - Report of proposed sale of securities
13.2.202402:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202401:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.2.202403:29EDGAR2Form 144 - Report of proposed sale of securities
03.2.202403:29EDGAR2Form 144 - Report of proposed sale of securities
03.2.202403:28EDGAR2Form 144 - Report of proposed sale of securities
03.2.202403:27EDGAR2Form 144 - Report of proposed sale of securities
03.2.202403:26EDGAR2Form 144 - Report of proposed sale of securities
01.2.202423:00GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
25.1.202413:03EDGAR2Form 8-K - Current report
25.1.202413:00GLOBEZentalis Pharmaceuticals Strengthens Management Team with..
08.1.202413:03EDGAR2Form 8-K - Current report
08.1.202413:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
04.1.202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202402:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
02.1.202422:49GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
21.12.202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202323:39GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
13.11.202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202323:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202313:00GLOBEZentalis to Participate in Investor Call Focused on Ovarian..
06.11.202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202315:04EDGAR2Form 8-K - Current report
06.11.202313:18GLOBEZentalis Pharmaceuticals Reports Third Quarter 2023..
01.11.202321:52GLOBEZentalis Pharmaceuticals Announces Inducement Grants Under..
07.10.202301:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.10.202301:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.10.202301:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.10.202323:00EDGAR2Form 8-K - Current report
05.10.202302:28EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

Delayed Upgrade Clock